gc012f
gracell
['gracell']
gracell biotechnologies presented long-term follow-up data from a multicenter study evaluating gc012f, a b-cell maturation antigen (bcma) and cd19 dual-targeted autologous car-t therapeutic candidate, in rrmm (abstract #8005) at the 2023 asco 
Research Intelligence, PharmaDJ, focus on China pharma & biotech industry and investment